Atlas Trials

PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)

Clinical trial NCT02062099 · COMPLETED

Trial details

NCT number
NCT02062099
Sponsor
University Hospital, Tours
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Memory ComplaintMild Cognitive ImpairmentAlzheimer Disease
Start date
2014-01-01
Primary completion
2018-05-22
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.